Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

FDA Rejects Promising Cancer Drug Developed in China

(MedPage Today) -- The FDA declined to approve a closely watched drug developed in China for an indication in non-small cell lung cancer (NSCLC), drugmaker Summit Therapeutics announced, though the investigational bispecific antibody could soon...

FDA Rejects Promising Cancer Drug Developed in China

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Monday 16 November →